Prendio-BioProcure, industry leaders in life science procurement solutions, are proud to announce their latest strategic ...

Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader ...

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...

The OsmoPRO ® MAX Automated Osmometer delivers the automation and data management capabilities required by modern clinical ...

Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...

You hear plenty about the cashmere caps, slip-on sneakers and limited-edition dive watches beloved by deep-pocketed men.

Fintel reports that on January 23, 2025, Barclays downgraded their outlook for Galapagos NV - Depositary Receipt () (NasdaqGS:GLPG) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 48 ...

LONDON, Jan. 23, 2025 /CNW/ -- Keith Hale has been appointed as Group CEO of Titian Software and Labguru (BioData Inc.), two ...

Evaxion Biotech (EVAX) announced the pricing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares and warrants ...